PortfoliosLab logoPortfoliosLab logo
APH vs. DOCS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APH vs. DOCS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphenol Corporation (APH) and Doximity, Inc. (DOCS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, APH achieves a 20.47% return, which is significantly higher than DOCS's -50.29% return.


APH

1D
2.54%
1M
5.46%
6M
19.49%
YTD
20.47%
1Y
66.32%
3Y*
57.63%
5Y*
37.08%
10Y*
28.66%

DOCS

1D
1.48%
1M
7.63%
6M
-49.68%
YTD
-50.29%
1Y
-65.21%
3Y*
-13.16%
5Y*
-16.04%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

APH vs. DOCS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
APH
Amphenol Corporation
20.47%96.08%41.30%31.85%-11.96%30.27%
DOCS
Doximity, Inc.
-50.29%-17.06%90.41%-16.45%-33.05%21.76%

Correlation

The correlation between APH and DOCS is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2021

0.26

The correlation between APH and DOCS shifts across timeframes, from -0.04 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

APH:

$199.59B

DOCS:

$4.12B

EPS

APH:

$4.57

DOCS:

$0.99

PE Ratio

APH:

35.51

DOCS:

22.27

PEG Ratio

APH:

1.18

DOCS:

1.90

PS Ratio

APH:

8.06

DOCS:

6.77

PB Ratio

APH:

14.97

DOCS:

4.51

Total Revenue (TTM)

APH:

$25.90B

DOCS:

$644.86M

Gross Profit (TTM)

APH:

$9.67B

DOCS:

$574.54M

EBITDA (TTM)

APH:

$7.45B

DOCS:

$245.76M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APH vs. DOCS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APH
APH Risk / Return Rank: 8282
Overall Rank
APH Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
APH Sortino Ratio Rank: 7979
Sortino Ratio Rank
APH Omega Ratio Rank: 8181
Omega Ratio Rank
APH Calmar Ratio Rank: 8282
Calmar Ratio Rank
APH Martin Ratio Rank: 8383
Martin Ratio Rank

DOCS
DOCS Risk / Return Rank: 66
Overall Rank
DOCS Sharpe Ratio Rank: 33
Sharpe Ratio Rank
DOCS Sortino Ratio Rank: 33
Sortino Ratio Rank
DOCS Omega Ratio Rank: 22
Omega Ratio Rank
DOCS Calmar Ratio Rank: 99
Calmar Ratio Rank
DOCS Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APH vs. DOCS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphenol Corporation (APH) and Doximity, Inc. (DOCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APHDOCSDifference
Sharpe ratioReturn per unit of total volatility

+2.75

Sortino ratioReturn per unit of downside risk

+3.96

Omega ratioGain probability vs. loss probability

1.27

0.72

+0.55

Calmar ratioReturn relative to maximum drawdown

2.36

-0.86

+3.22

Martin ratioReturn relative to average drawdown

6.05

-1.33

+7.38

APH vs. DOCS - Sharpe Ratio Comparison

The current APH Sharpe Ratio is 1.55, which is higher than the DOCS Sharpe Ratio of -1.20. The chart below compares the historical Sharpe Ratios of APH and DOCS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

APH vs. DOCS - Drawdown Comparison

The maximum APH drawdown since its inception was -63.41%, smaller than the maximum DOCS drawdown of -82.35%. Use the drawdown chart below to compare losses from any high point for APH and DOCS.


Loading charts...

Drawdown Indicators


APHDOCSDifference

Max Drawdown

Largest peak-to-trough decline

-63.41%

-82.35%

+18.94%

Max Drawdown (1Y)

Largest decline over 1 year

-28.19%

-76.03%

+47.84%

Max Drawdown (3Y)

Largest decline over 3 years

-28.19%

-78.34%

+50.15%

Max Drawdown (5Y)

Largest decline over 5 years

-28.73%

-82.35%

+53.62%

Max Drawdown (10Y)

Largest decline over 10 years

-37.56%

Current Drawdown

Current decline from peak

-7.99%

-78.43%

+70.44%

Average Drawdown

Average peak-to-trough decline

-13.54%

-57.48%

+43.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.99%

49.18%

-38.19%

Volatility

APH vs. DOCS - Volatility Comparison

Amphenol Corporation (APH) has a higher volatility of 14.40% compared to Doximity, Inc. (DOCS) at 12.10%. This indicates that APH's price experiences larger fluctuations and is considered to be riskier than DOCS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


APHDOCSDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.40%

12.10%

+2.30%

Volatility (6M)

Calculated over the trailing 6-month period

37.93%

45.83%

-7.90%

Volatility (1Y)

Calculated over the trailing 1-year period

43.06%

54.65%

-11.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.17%

68.36%

-37.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.11%

69.80%

-41.69%

Dividends

APH vs. DOCS - Dividend Comparison

APH's dividend yield for the trailing twelve months is around 0.56%, while DOCS has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
APH
Amphenol Corporation
0.56%0.55%0.79%1.07%1.06%0.89%0.80%0.89%1.09%0.80%0.86%1.01%
DOCS
Doximity, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

APH vs. DOCS - Financials Comparison

This section allows you to compare key financial metrics between Amphenol Corporation and Doximity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
7.62B
145.37M
(APH) Total Revenue
(DOCS) Total Revenue
Values in USD except per share items

APH vs. DOCS - Profitability Comparison

The chart below illustrates the profitability comparison between Amphenol Corporation and Doximity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
36.8%
86.7%
Portfolio components
APH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Amphenol Corporation reported a gross profit of 2.80B and revenue of 7.62B. Therefore, the gross margin over that period was 36.8%.

DOCS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Doximity, Inc. reported a gross profit of 125.97M and revenue of 145.37M. Therefore, the gross margin over that period was 86.7%.

APH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Amphenol Corporation reported an operating income of 1.83B and revenue of 7.62B, resulting in an operating margin of 24.0%.

DOCS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Doximity, Inc. reported an operating income of 24.83M and revenue of 145.37M, resulting in an operating margin of 17.1%.

APH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Amphenol Corporation reported a net income of 2.35B and revenue of 7.62B, resulting in a net margin of 30.8%.

DOCS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Doximity, Inc. reported a net income of 19.11M and revenue of 145.37M, resulting in a net margin of 13.2%.


Frequently Asked Questions


APH and DOCS have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APH has higher volatility (14.40%) compared to DOCS (12.10%). In terms of maximum drawdown, APH dropped -63.41% vs DOCS's -82.35%.

APH currently has the higher Sharpe Ratio (1.55 vs -1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for APH and DOCS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer